美拉诺坦Ⅱ
Melanotan II;N-Acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-lysinamide (2->7)-lactam;Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2;Ac-[Nle4,Asp5,D-Phe7,Lys10]alpha-MSH-(4-10)-NH2;Melanotan II acetate salt;Acetyl-(Nle?00Asp?00D-Phe?00Lys??)-cyclo-α-MSH(4-10)amide;Acetyl-(Nle4,Asp5,D-Phe7,Lys10)-cyclo-α-MSH (4-10) amide;Melanotan II Acetate;Melanotan Ц;Melanotan-2;Melanotan-II;Melanotan-II (MT-II);(3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxamide;Ac-[Nle4Asp5D-Phe7Lys10]α-MSH-(4-10)-NH2;Ac-{NLE}DH{D-PHE}RWK-NH2;vial;MT2;MTII;MT-Ⅱ;Melanotan 2;MalanotanIi;Melanotan ②;mt2 receptor;Mt-Ii(Melanotan);MT-II;Melanotan (MT)-II;Melatonan;L-Lysinamide, N-acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-, cyclic (2-7)-peptide;Melanotan -Ii;C50H69N15O9;Asp5;Melan;DSIP;(3S,6S,9R,12S,15S,23S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-3-yl)methyl)-15-((S)-2-acetamidohexanamido)-9-benzyl-6-(3-((diaminomethylene)amino)propyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxamide;(3S,6S,9R,12S,15S,23S)-9-benzyl-6-{3-[(diaminomethylidene)amino]propyl}-15-[(2S)-2-acetamidohexanamido]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxamide;BDBM50184359;GTPL1323;MelanotanII;J-004435;L-LYSINAMIDE, N-ACETYL-L-NORLEUCYL-L-.ALPHA.-ASPARTYL-L-HISTIDYL-D-PHENYLALANYL-L-ARGINYL-L-TRYPTOPHYL-, CYCLIC (2->7)-PEPTIDE;MFCD06795842;NCGC00167281-01;F93947;Ac-[Nle4Asp5D-Phe7Lys10]alpha-MSH-(4-10)-NH2;121062-08-6 (non-salt);CHEBI:195326;Q423855;EX-A7394;SCHEMBL1047531;ebi_340792;HS-2017;HY-P0267;UNII-UPF5CJ93X7;MELANOTAN II [WHO-DD];(3S,6S,9R,12S,15S,23S)-15-((S)-2-acetylamino-hexanoylamino)-9-benzyl-6-(3-guanidino-propyl)-12-(3H-imidazol-4-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18hexaaza-cyclotricosane-23-carboxylic acid amide;(3S,6S,9R,12S,15S,23S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-3-yl)methyl)-15-((S)-2-acetamidohexanamido)-9-benzyl-6-(3-guanidinopropyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxamide;DTXSID90153135;CHEMBL430239;UPF5CJ93X7;AKOS015994654;121062-08-6;BDBM50027084;Melanotan Ⅱ;Melanotan II?;DA-55328;(3S,6S,9R,12S,15S,23S)-9-BENZYL-6-(3-CARBAMIMIDAMIDOPROPYL)-15-[(2S)-2-ACETAMIDOHEXANAMIDO]-12-(1H-IMIDAZOL-4-YLMETHYL)-3-(1H-INDOL-3-YLMETHYL)-2,5,8,11,14,17-HEXAOXO-1,4,7,10,13,18-HEXAAZACYCLOTRICOSANE-23-CARBOXAMIDE;mt-2